Global Peripheral Intravenous Catheters (PIVC) Market Size By Type (Ported Peripheral Intravenous Catheters (PIVC), Non-Ported Peripheral Intravenous Catheters (PIVC)), By Application (Hospitals, Clin...

The Global Peripheral Intravenous Catheters (PIVC) Market was valued at USD 4.7 billion in 2023 and is projected to reach USD 8.1 billion by 2031, expanding at a CAGR of 6.8% during the forecast period from 2023 to 2031. PIVCs are widely used in hospitals and healthcare settings to administer medications, fluids, and blood products directly into the bloodstream. The market is experiencing strong growth due to the increasing prevalence of chronic diseases, rising number of hospital admissions, and growing demand for minimally invasive procedures.

Innovations in catheter materials, antimicrobial coatings, and needle safety technologies are significantly improving patient outcomes and reducing complications such as phlebitis and infections. Moreover, the aging global population and expanding healthcare infrastructure in emerging markets further bolster market growth.

Drivers:

1. Rising Incidence of Chronic Diseases:

An increase in the prevalence of chronic illnesses such as diabetes, cancer, and cardiovascular diseases necessitates frequent hospitalizations and intravenous therapies, boosting demand for PIVCs.

2. Growth in Surgical Procedures:

With a surge in surgical volumes globally—both elective and emergency—there is heightened utilization of PIVCs for pre-, intra-, and post-operative patient care.

3. Technological Advancements in Catheter Design:

Manufacturers are introducing innovative catheters with features like closed systems, blood control technology, and antimicrobial coatings to enhance safety and reduce complications.

Restraints:

1. Risk of Catheter-Associated Infections:

Improper insertion or maintenance of PIVCs can lead to bloodstream infections, prompting concerns over safety and increasing scrutiny by healthcare regulators.

2. Limited Skilled Workforce in Low-Resource Settings:

In many developing countries, a shortage of trained professionals can affect the proper use and management of PIVCs, leading to complications and reducing adoption.

Opportunity:

1. Expansion of Healthcare Access in Emerging Markets:

The growing healthcare infrastructure in Asia-Pacific, Latin America, and Africa presents significant opportunities for market expansion, especially with rising awareness of safe IV practices.

2. Increased Adoption of Home Healthcare:

The shift towards home-based treatment for chronic illnesses is encouraging the use of easy-to-insert, self-administered PIVCs, creating new growth avenues.

Market by System Type Insights:

By system type, the Short Peripheral Intravenous Catheters segment accounted for the largest market share in 2023. These catheters are preferred due to their ease of insertion, affordability, and suitability for short-term fluid or medication administration. However, the Integrated/Closed PIVCs segment is anticipated to grow at the fastest rate, supported by rising safety standards and infection control guidelines globally.

Market by End-use Insights:

The Hospitals segment emerged as the dominant end-user in 2023, contributing more than 50% of the global revenue. High patient turnover and the need for quick vascular access in emergency and intensive care units underpin this dominance. Meanwhile, the Home Healthcare segment is projected to witness notable growth, driven by increasing elderly population and chronic disease management at home.

Market by Regional Insights:

North America led the global PIVC market in 2023, owing to its robust healthcare infrastructure, high per capita healthcare expenditure, and favorable reimbursement policies. The Asia-Pacific region is expected to exhibit the highest CAGR during the forecast period, fueled by expanding healthcare access, rising chronic disease burden, and governmental investments in public health.

Competitive Scenario:

Key players in the Global PIVC Market include Becton, Dickinson and Company, B. Braun Melsungen AG, Smiths Medical, Terumo Corporation, Nipro Medical Corporation, Teleflex Incorporated, and Medline Industries, Inc. These companies are heavily investing in R&D to introduce advanced safety-engineered catheters and are expanding their geographic footprint through strategic partnerships and acquisitions.

Scope of Work – Global Peripheral Intravenous Catheters (PIVC) Market

Report Metric Details

Market Size (2023) USD 4.7 Billion

Projected Market Size (2031) USD 8.1 Billion

CAGR (2023–2031) 6.8%

Market Segments By System Type (Short PIVC, Integrated/Closed PIVC), End-use (Hospitals, Clinics, Home Healthcare), Region

Growth Drivers Increasing chronic disease burden, growth in surgical procedures, technological innovation

Opportunities Expansion in emerging markets, rise in home healthcare adoption

Key Market Developments:

2023: B. Braun Melsungen AG launched a next-gen safety IV catheter with integrated blood control to minimize exposure risks.

2023: BD expanded its vascular access portfolio with a new line of antimicrobial-coated PIVCs targeting infection prevention.

2024: Smiths Medical introduced a smart PIVC tracking solution integrated with hospital EMRs for better monitoring and care outcomes.

FAQs:

1. What is the current market size of the Global Peripheral Intravenous Catheters (PIVC) Market?

The market size was valued at USD 4.7 billion in 2023.

2. What is the major growth driver of the Global Peripheral Intravenous Catheters (PIVC) Market?

The rising incidence of chronic diseases and the growing number of surgical procedures are key drivers.

3. Which is the largest region during the forecast period in the Global Peripheral Intravenous Catheters (PIVC) Market?

North America holds the largest market share, with Asia-Pacific expected to grow at the fastest rate.

4. Which segment accounted for the largest market share in the Global Peripheral Intravenous Catheters (PIVC) Market?

The Short Peripheral Intravenous Catheters segment held the largest share in 2023.

5. Who are the key market players in the Global Peripheral Intravenous Catheters (PIVC) Market?

Major players include BD, B. Braun, Smiths Medical, Terumo, Nipro, Teleflex, and Medline Industries.

Would you like a visual chart or infographic to complement this description?